Methodological Aspects of Multicenter Studies with Quantitative PET
Reference40 articles.
1. Fletcher, J.W., Djulbegovic, B., Soares, H.P., Siegel, B.A., Lowe, V.J., Lyman, G.H. et al. (2008) Recommendations on the use of F-18-FDG PET in oncology. J Nucl Med
49(3), 480–508. 2. Hoekstra, C.J., Stroobants, S.G., Hoekstra, O.S., Vansteenkiste, J., Biesma, B., Schramel, F.J., et al. (2003) The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment. Lung Cancer
39(2), 151–7. 3. Mijnhout, G.S., Borgstein, P.J., Hoekstra, O.S., van Diest, P.J., Pijpers, R., Meijer, S., et al. (1999) Potential value of FDG-PET for initial regional staging in melanoma. J Invest Dermatol
113(3), 514. 4. van Tinteren, H., Hoekstra, O.S., Smit, E.F., van den Bergh, J.H., Schreurs, A.J., Stallaert, R.A., et al. (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet
359(9315), 1388–92. 5. Vansteenkiste, J.F., Stroobants, S.G. (2001) The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J
17(4), 802–20.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|